Redefining life with chronic pain
Remedee Labs has raised $12.8M in total funding. The most recent round was Series A. The last funding was announced in December 2022.
Remedee Labs's investors include Bpifrance, BNP Paribas, Partech, Supernova Invest, HCVC.
Remedee Labs is headquartered in Montbonnot-saint-martin, France.
Redefining life with chronic pain
Remedee Labs is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Remedee Labs — Funding & Investors." VCBacked, December 6, 2022, https://www.vcbacked.co/company/remedee-labs. Accessed September 30, 2026.
VCBacked. (2022). Remedee Labs — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/remedee-labs
{{cite web |title=Remedee Labs — Funding & Investors |url=https://www.vcbacked.co/company/remedee-labs |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated